Stock Analysis | Verisk Analytics Outlook - A Bearish Setup Amid Mixed Fundamentals

1. Market Snapshot

Headline takeaway: Verisk Analytics (VRSK) is facing a weak technical setup with no bullish signals, and the stock has dropped 5.62% recently.

While the stock's fundamentals remain strong with an internal diagnostic score of 8.07, the technicals are underperforming with a score of 3.01, suggesting investors should proceed with caution.

2. News Highlights

• May 30 - UFC Antitrust Lawsuit: A new class action lawsuit was filed against the UFC on behalf of non-UFC MMA fighters. While unrelated to Verisk, it reflects growing legal scrutiny in professional sports, which may weigh on market sentiment for sports-related stocks.
• May 30 - MLB and Professional Softball Partnership: Major League Baseball announced a partnership with a new women’s softball league. This news highlights a broader interest in professional sports but offers no direct benefit to Verisk.
• May 30 - Eco-Friendly Pest Control Fundraising: Med-X, Inc. launched a $10 million Regulation A+ offering for eco-friendly pest control solutions. While not directly related, it reflects growing interest in specialized, sustainable solutions, an area Verisk is involved in through data analytics.

3. Analyst Views & Fundamentals

Analysts are split on Verisk Analytics, with a simple average rating of 3.33 and a performance-weighted rating of 1.10, reflecting low confidence. The stock has fallen in the last five days, aligning with the generally negative analyst outlook.

• Current Price Trend: Fallen by -5.62%
• Analyst Ratings in the Past 20 Days:
  • UBS (Alex Kramm): Neutral; historical win rate 50.0%
  • Raymond James (Charles Gregory Peters): Buy; historical win rate 0.0%
  • Morgan Stanley (Toni Kaplan): Neutral; historical win rate 50.0%
• Fundamental Highlights:
  • P/B Ratio: 10.88 - internal diagnostic score: 3
  • Current Assets Turnover Ratio: 1.33 - internal diagnostic score: 1
  • Operating Revenue YoY Growth: 7.38% - internal diagnostic score: 1
  • Non-current Liabilities / Total Liabilities: 79.93% - internal diagnostic score: 3
  • Long-term Debt to Working Capital Ratio: 7.50% - internal diagnostic score: 1
  • Cash to Market Value: -1.26 - internal diagnostic score: 1

4. Money-Flow Trends

Big-money investors are showing cautious optimism, with extra-large inflows at 58.14% and a fund flow score of 7.34. This contrasts with negative small and medium inflows, suggesting retail investors are selling off while larger institutions are accumulating or maintaining positions.

5. Key Technical Signals

Verisk’s technical outlook is weak, with 3 bearish indicators and 0 bullish ones in the past five days. Here’s a breakdown of the signals:

• WR Oversold: Internal diagnostic score: 3.41 - A neutral rise indicator.
• Bearish Engulfing: Internal diagnostic score: 1.57 - A strong bearish signal.
• Marubozu White: Internal diagnostic score: 1.00 - Suggests a bearish continuation.
• RSI Oversold: Internal diagnostic score: 6.05 - A neutral signal with mixed returns historically.

Recent Chart Patterns:

• August 11, 2025: WR Oversold
• August 6, 2025: WR Oversold, RSI Oversold
• August 5, 2025: WR Oversold, RSI Oversold
• August 8, 2025: WR Oversold, Marubozu White, RSI Oversold
• August 7, 2025: WR Oversold, Bearish Engulfing, RSI Oversold

The key insight from the technical analysis is that “Bearish signals are obviously dominant (3 bearish vs 0 bullish)”, and the market is in a volatile and unclear state, with the overall trend suggesting a sell bias.

6. Conclusion

Investors should be cautious with Verisk Analytics given the weak technical signals and mixed analyst opinions. While the fundamental score is strong at 8.07, the recent price drop and bearish chart patterns suggest a wait-and-see approach until further clarity emerges on the stock’s direction. Consider monitoring earnings or major industry developments for a clearer signal before entering new positions.